CLOSE
CLOSE
Wright Medical Group, Inc.
Search
HomeInvestor RelationsCorporate Governance › Management Team & Directors

Management Team & Directors

“A strong management team is the backbone of any successful company. The entire Wright team is committed to delighting our customers every day, providing a rewarding and fun environment for our employees and delivering an exceptional return to our shareholders. We are also dedicated to maintaining and promoting the highest standards of ethical and legal conduct in all of the markets that we serve.”
Robert Palmisano
President and Chief Executive Officer
Management Team
Click on photo for bio
  • Biography PhotoRobert J. PalmisanoPresident & CEO
  • Robert J. Palmisano was appointed President and Chief Executive Officer and Executive Director of Wright Medical Group N.V. effective October 2015 in connection with the merger of Wright Medical Group, Inc. and Tornier N.V. Mr. Palmisano also serves as President and Chief Executive Officer of Wright Medical Group, Inc., a position he has held since September 2011. He has significant experience leading publicly-traded medical device companies, serving as President and Chief Executive Officer of ev3 Inc., a global endovascular device company, from April 2008 to July 2010, when it was acquired by Covidien plc. Prior to leading ev3, Mr. Palmisano was President and Chief Executive Officer of IntraLase Corp. from 2003 to 2007, and previously President and Chief Executive Officer of MacroChem Corporation from 2001 to 2003. Earlier in his career, he served as President and Chief Executive Officer of Summit Technology Inc. until it was acquired by Alcon Inc., and in various executive positions at Bausch & Lomb Incorporated. Mr. Palmisano currently serves on the Providence College Board of Trustees. Mr. Palmisano previously served on the board of directors of Bausch & Lomb, a privately-held company, and ev3 Inc., Osteotech, Inc., and Abbott Medical Optics, Inc., all public companies. Mr. Palmisano holds a B.A. degree in Political Science from Providence College.
  • Biography PhotoLance A. BerrySr. Vice President & Chief Financial Officer
  • Lance A. Berry was appointed Senior Vice President and Chief Financial Officer of Wright Medical Group N.V. effective October 2015. Mr. Berry also serves as Senior Vice President and Chief Financial Officer of Wright Medical Group, Inc., a position he has held since December 2009. He served as a Vice President of Wright Medical Group, Inc. from 2004 to December 2009 and Corporate Controller from 2002 to December 2009. Prior to Wright, he was an accountant in the auditing division of Arthur Andersen, LLP, from 1995 to 2002, where he held various positions of increasing responsibility, most recently as Audit Manager, and his clients consisted primarily of multinational and public companies. Mr. Berry is a certified public accountant.
  • Biography PhotoRobert P. BurrowsSr. Vice President, Supply Chain
  • Robert P. Burrows was appointed Senior Vice President, Supply Chain of Wright Medical Group N.V. effective October 2015. Mr. Burrows served as Senior Vice President, Supply Chain of Wright Medical Group, Inc. from August 2014 to October 2015. Prior to Wright, Mr. Burrows served as the Managing Principal of The On-Point Group, a privately held logistics and supply chain consultancy, from July 1994 through July 2014. While at On-Point, Bob led over 40 client engagements, most recently as an operations consultant overseeing the transition and expansion of Wright Medical’s extremities and biologics manufacturing in the wake of Wright’s sale of its OrthoRecon business, including a substantial portion of its manufacturing infrastructure, to MicroPort.
  • Biography PhotoPeter S. CookePresident, International
  • Peter S. Cooke was appointed President, International of Wright Medical Group N.V. effective October 2015. Mr. Cooke served as President, International of Wright Medical Group, Inc. from January 2014 to October 2015 and served as Senior Vice President, International of Wright from January 2013 to January 2014. Prior to Wright, Mr. Cooke served as Vice President and General Manager, Vascular Therapies Emerging Markets of Covidien plc, a global healthcare products company, from 2010 to January 2013. Prior to Covidien, Mr. Cooke served in various sales roles for ev3 Inc., a global endovascular device company acquired by Covidien in July 2010, including Vice President and General Manager, International from July 2008 to July 2010; Vice President, General Manager, International from November 2006 to June 2008; Vice President, Sales International from January 2005 until November 2006; and Regional Director, Asia Pacific and China from February 2003 until January 2005. Prior to ev3, Mr. Cooke spent 11 years at Guidant Corporation, three years at Baxter Healthcare Corporation and two years at St. Jude Medical, Inc.
  • Biography PhotoKevin CordellPresident, U.S.
  • Kevin D. Cordell was appointed President, U.S. effective June 2016. Mr. Cordell served as President, Lower Extremities and Biologics of Wright Medical Group N.V. from October 2015 to June 2016 and of Wright Medical Group, Inc. from September 2014 to October 2015. Prior to Wright, Mr. Cordell served as Vice President of Sales for the GI Solutions business at Covidien plc, a leading global healthcare products company, from May 2012 to September 2014. While at Covidien, he also served as Vice President of Sales and Global Marketing for its Peripheral Vascular business from July 2010 to May 2012. He joined Covidien in July 2010 through the acquisition of ev3 Inc., a global endovascular device company, where he served as Vice President, U.S. Sales from January 2009 to July 2010. Prior to ev3, Mr. Cordell served as Vice President, Global Sales of FoxHollow Technologies, Inc. from March 2007 to October 2007. Earlier in his career, Mr. Cordell also held various positions of increasing responsibility for Johnson & Johnson’s Cordis Cardiology and Centocor companies. Mr. Cordell received his bachelor’s degree in finance from the University of Oklahoma. He currently serves on the board of directors of TissueGen, Inc., a privately-held developer of biodegradable polymer technology for implantable drug delivery.
  • Biography PhotoWilliam L. GriffinSr. Vice President & General Manager, BioMimetic Therapeutics
  • William L. Griffin was appointed Senior Vice President and General Manager, BioMimetic Therapeutics at Wright Medical Group N.V. effective October 2015. Mr. Griffin served as Senior Vice President and General Manager, BioMimetic Therapeutics of Wright Medical Group, Inc. from March 2013 to October 2015. Mr. Griffin served as Sr. Vice President of Global Operations of Wright from July 2008 to March 2013. Prior to joining Wright, Mr. Griffin had global responsibility for all operations at Smith & Nephew, Inc. since 2002. From 1997 until 2002, he held positions at Johnson & Johnson Medical, including serving as its Vice President and General Manager. Mr. Griffin began his career in the medical device industry with Becton, Dickinson and Company where he spent 23 years with the final position of Vice President of Global Supply Chain Services.
  • Biography PhotoJames A. LightmanSr. Vice President, General Counsel and Secretary
  • James A. Lightman was appointed Senior Vice President, General Counsel and Secretary of Wright Medical Group N.V. effective October 2015. Mr. Lightman also serves as Senior Vice President, General Counsel and Secretary of Wright Medical Group, Inc., a position he has held since December 2011. Mr. Lightman has more than two decades of corporate legal experience and brings a diverse skill set in managing complex legal and business matters for public and private healthcare and medical device companies. He has held chief legal officer positions with leading healthcare technology companies including Eyeonics, Inc., IntraLase Corp., Summit Autonomous Inc. and Amicore, Inc. In addition, Lightman served as Vice President and Assistant General Counsel from February 2008 to November 2009 at Bausch & Lomb, where he most recently held the position of Vice President, Global Sales Operations until August 2011. Mr. Lightman holds a juris doctor degree cum laude from the Boston University School of Law and a bachelor's degree magna cum laude from the Boston University School of Management. He is a member of the Massachusetts Bar, the California Bar (MJP Program), the American Health Lawyers Association and the American Corporate Counsel Association.
  • Biography PhotoGregory MorrisonSenior Vice President, Human Resources
  • Gregory Morrison was appointed Senior Vice President, Human Resources of Wright Medical Group N.V. effective October 2015. Mr. Morrison previously served as Senior Vice President, Global Human Resources and HPMS (High Performance Management System) at Tornier N.V. from January 2014 to October 2015 and Global Vice President, Human Resources from December 2010 to January 2014. Prior to Tornier, Mr. Morrison served as Senior Vice President, Human Resources at ev3 Inc., Inc., a global endovascular device company acquired by Covidien plc in July 2010, from August 2007 to December 2010, and as Vice President, Human Resources of ev3 from May 2002 to August 2007. Prior to ev3, Mr. Morrison served as Vice President of Organizational Effectiveness for Thomson Legal & Regulatory from March 1999 to February 2002 and Vice President of Global Human Resources for Schneider Worldwide, which was acquired by Boston Scientific Corporation, from 1988 to March 1999. Mr. Morrison has a Bachelor of Arts in English and Communications from North Adams State College and a Master of Arts in Corporate Communications from Fairfield University.
  • Biography PhotoJ. Wesley PorterSr. Vice President, Chief Compliance Officer
  • Wes Porter was appointed Senior Vice President and Chief Compliance Officer of Wright Medical Group N.V. effective October 2015. Mr. Porter served as Senior Vice President and Chief Compliance Officer of Wright Medical Group, Inc. from October 2014 to October 2015 and served as Vice President, Compliance from July 2014 to October 2014. Mr. Porter brings a deep skill set in implementing and managing corporate compliance programs for public medical device and pharmaceutical companies. Mr. Porter served as Senior Corporate Counsel, Compliance, HIPAA and Reimbursement from April 2006 to May 2009 at Smith & Nephew in Memphis. Most recently, he held the positions of Vice President, Ethics and Compliance from June 2009 to September 2012 at CareFusion and Vice President, Deputy Compliance Officer from September 2012 to February 2014 at Allergan. Mr. Porter holds a juris doctor degree and a masters in health administration from Saint Louis University and a bachelor's degree from Occidental College. He is a member of the Illinois Bar, the Missouri Bar, the Tennessee Bar, the American Health Lawyers Association and the Health Care Compliance Association.
  • Biography PhotoJulie D. TracySr. Vice President, Chief Communications Officer
  • Julie D. Tracy was appointed Senior Vice President and Chief Communications Officer of Wright Medical Group N.V. effective October 2015. Ms. Tracy served as Senior Vice President and Chief Communications Officer of Wright Medical Group, Inc. from October 2011 to October 2015. Ms. Tracy is responsible for corporate communications and developing Wright's relationship with shareholders and institutional investors. She joined Wright with over 25 years of experience in medical device marketing and sales. Ms. Tracy previously served as Chief Communications Officer for Epocrates, Inc. from March 2011 to September 2011 and as Senior Vice President and Chief Communications Officer for ev3 Inc. from January 2008 to July 2010. Prior to ev3, Ms. Tracy held marketing and investor relations positions at Kyphon Inc. and Thoratec Corporation. Ms. Tracy holds a B.S. degree in business administration from the University of Southern California and received her MBA from Pepperdine University in Los Angeles. Ms. Tracy currently serves as a member of the Board of Directors for the National Investor Relations Institute, the professional association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents.
  • Biography PhotoJennifer S. WalkerSr. Vice President, Process Improvement
  • Jennifer S. Walker was appointed Senior Vice President, Process Improvement of Wright Medical Group N.V. effective October 2015. Ms. Walker served as Senior Vice President, Process Improvement of Wright Medical Group, Inc. from December 2011 to October 2015 and as Vice President and Corporate Controller from December 2009 to December 2011. Since joining Wright's finance organization in 1993, she served as Assistant Controller, Director, Financial Reporting and Risk Management, Director, Corporate Tax and Risk Management and Tax Manager. Before Wright, she was a Senior Tax Accountant with Arthur Andersen LLP. Ms. Walker is a Certified Public Accountant.
Directors
  • Gary D. BlackfordNon-Executive Director
    Formerly President &
    Chief Executive Officer, Universal Hospital Services, Inc.Director Since 2008
  • Mr. Blackford was appointed a Non-Executive Director of Wright Medical Group N.V. effective October 2015 in connection with the merger of Wright Medical Group, Inc. and Tornier N.V. Previously, Mr. Blackford served as a director of Wright Medical Group, Inc. from May 2008 to October 2015. Mr. Blackford served as Chairman of the Board of Directors of Universal Hospital Services, Inc. from 2007 to February 2015, and served as President, Chief Executive Officer and a member of its Board of Directors from 2002 to February 2015. From 2001 to 2002, Mr. Blackford was Chief Executive Officer for Curative Health Services Inc. From 1999 to 2001, Mr. Blackford served as Chief Executive Officer for ShopforSchool, Inc. He was the Chief Operating Officer for Value Rx from 1995 to 1998 and the Chief Operating Officer and Chief Financial Officer of MedIntel Systems Corporation from 1993 to 1994. He is a member of the board of directors of Halyard Heath, Inc. and EnteroMedics Inc., both public companies. Mr. Blackford also served on the board of directors of Compex Technologies, Inc., a public company, from 2005 until its acquisition by Encore Medical Corporation.
  • Sean D. CarneyNon-Executive Director
    Managing Director,
    Warburg Pincus LLC & General Partner, Warburg Pincus & Co.
  • Mr. Carney has served as a Non-Executive Director since July 2006. From May 2010 to October 2015, Mr. Carney served as Chairman of the Board of Directors of Tornier N.V. Mr. Carney was appointed as a director of Tornier N.V. in connection with the securityholders’ agreement that Tornier N.V. entered into with certain of its shareholders. Since 1996, Mr. Carney has been employed by Warburg Pincus LLC, a private equity firm, and has served as a Member and Managing Director of Warburg Pincus LLC and a General Partner of Warburg Pincus & Co. since January 2001. Prior to joining Warburg Pincus, Mr. Carney was a consultant at McKinsey & Company, Inc., a management consulting company. Mr. Carney previously served on the board of directors of DexCom, Inc., a publicly held medical device company, Arch Capital Group Ltd., a publicly held company, MBIA Inc., a publicly held company, and several privately held companies. Mr. Carney received a Master of Business Administration from Harvard Business School and a Bachelor of Arts from Harvard College.
  • John L. MiclotNon-Executive DirectorPresident and Chief Executive Officer, LinguaFlex, Inc.Director Since 2007
  • Mr. Miclot was appointed a Non-Executive Director of Wright Medical Group N.V. effective October 2015 in connection with the merger of Wright Medical Group, Inc. and Tornier N.V. Previously, Mr. Miclot served as Director of Wright Medical Group, Inc. from March 2007 to October 2015. Mr. Miclot has served as President and Chief Executive Officer and a member of the board of directors of LinguaFlex, Inc., a medical device company focused on treatment of sleep disordered breathing, since August 2015. From December 2011 to December 2014, he served as Chief Executive Office and a member of the board of directors of Tengion Inc., a publicly held company that focused on organ and cell regeneration. Prior to joining Tengion, Mr. Miclot was an Executive-in-Residence at Warburg Pincus LLC. From 2008 to 2010, he was President and Chief Executive Officer of CCS Medical, Inc., a provider of products and services for patients with chronic diseases. He served as President and Chief Executive Officer of Respironics, Inc., a provider of sleep and respiratory products, from 2003 until 2008, and prior to such time, served in various positions at Respironics, Inc. from 1998 to 2003, including Chief Strategic Officer and President of the Homecare Division. From 1995 to 1998, he served as Senior Vice President, Sales and Marketing of Healthdyne Technologies, Inc., a medical device company that was acquired by Respironics, Inc. in 1998. Mr. Miclot spent the early part of his medical career at DeRoyal Industries, Inc., Baxter International Inc., Ohmeda Medical, Inc., and Medix Inc. Mr. Miclot serves on the board of directors of Dentsply International, a publicly held company, and serves as Chairman and a member of the board of directors of Breathe Technologies, Inc., a privately held company. Mr. Miclot also serves as a director of the Pittsburgh Zoo and PPG Aquarium, charitable and educational institutions, serves on the University of Iowa Tippie College of Business board of advisors and serves as an industrial advisor to EQT Partners, an investment company. Mr. Miclot previously served on the board of directors of ev3 Inc., a global endovascular device company, prior to the sale of the company in 2010.
  • Kevin C. O’BoyleNon-Executive Director
    Formerly Interim Vice Chairman, Tornier
    N.V. and Chief Financial Officer, NuVasive, Inc.
  • Mr. O’Boyle has served as a Non-Executive Director since June 2010. In November 2012, Mr. O’Boyle served as Interim Vice Chairman of Tornier N.V., a position he held for about a year. From December 2010 to July 2011, Mr. O’Boyle served as Senior Vice President and Chief Financial Officer of Advanced BioHealing Inc., a medical device company which was acquired by Shire plc in July 2011. From January 2003 until December 2009, Mr. O’Boyle served as Chief Financial Officer of NuVasive, Inc., a medical device orthopedics company specializing in spinal disorders. Prior to that time, Mr. O’Boyle served in various positions during his six years with ChromaVision Medical Systems, Inc., a publicly held medical device company specializing in the oncology market, including as its Chief Financial Officer and Chief Operating Officer. Mr. O’Boyle also held various positions during his seven years with Albert Fisher North America, Inc., a publicly held international food company, including Chief Financial Officer and Senior Vice President of Operations. Mr. O’Boyle currently serves on the board of directors of Sientra, Inc., GenMark Diagnostics, Inc. and ZELTIQ Aesthetics, Inc., all public companies. Mr. O’Boyle previously served on the board of directors of Durata Therapeutics, Inc., a public company acquired by Actavis plc in November 2014. Mr. O’Boyle received a Bachelor of Science in Accounting from the Rochester Institute of Technology and successfully completed the Executive Management Program at the University of California Los Angeles, John E. Anderson Graduate Business School.
  • Robert J. PalmisanoExecutive DirectorPresident and Chief Executive Officer, Wright Medical Group N.V.Director Since 2011
  • Robert J. Palmisano was appointed President and Chief Executive Officer and Executive Director of Wright Medical Group N.V. effective October 2015 in connection with the merger of Wright Medical Group, Inc. and Tornier N.V. Mr. Palmisano also serves as President and Chief Executive Officer of Wright Medical Group, Inc., a position he has held since September 2011. He has significant experience leading publicly-traded medical device companies, serving as President and Chief Executive Officer of ev3 Inc., a global endovascular device company, from April 2008 to July 2010, when it was acquired by Covidien plc. Prior to leading ev3, Mr. Palmisano was President and Chief Executive Officer of IntraLase Corp. from 2003 to 2007, and previously President and Chief Executive Officer of MacroChem Corporation from 2001 to 2003. Earlier in his career, he served as President and Chief Executive Officer of Summit Technology Inc. until it was acquired by Alcon Inc., and in various executive positions at Bausch & Lomb Incorporated. Mr. Palmisano currently serves on the Providence College Board of Trustees. Mr. Palmisano previously served on the board of directors of Bausch & Lomb, a privately-held company, and ev3 Inc., Osteotech, Inc., and Abbott Medical Optics, Inc., all public companies. Mr. Palmisano holds a B.A. degree in Political Science from Providence College.
  • Amy S. PaulNon-Executive DirectorFormerly Group Vice President, International, C.R. Bard, Inc.Director Since 2008
  • Ms. Paul was appointed a Non-Executive Director of Wright Medical Group N.V. effective October 2015 in connection with the merger of Wright Medical Group, Inc. and Tornier N.V. Previously, Ms. Paul served as a Director of Wright Medical Group, Inc. from May 2008 to October 2015. Ms. Paul retired in 2008 following a 26-year career with C.R. Bard, Inc., a medical device company, most recently serving as the Group Vice President-International since 2003. She served in various positions at C.R. Bard, Inc. from 1982 to 2003, including President of Bard Access Systems, Inc., President of Bard Endoscopic Technologies, Vice President and Business Manager of Bard Ventures, Vice President of Marketing of Bard Cardiopulmonary Division, Marketing Manager for Davol Inc., and Senior Product Manager for Davol Inc. Ms. Paul previously served on the board of directors of Derma Sciences, Inc., a public company, and Viking Systems, Inc., a public company, until October 2012 when it was acquired by Conmed Corporation. Ms. Paul was a commissioner of the Northwest Commission on Colleges and Universities from 2010 to 2013. Ms. Paul serves on the President's Innovation Network at Westminster College.
  • David D. StevensChairman, Non-Executive Director
    Formerly Chief Executive Officer,
    Accredo Health Group, Inc., a subsidiary of Medco Health Solutions, Inc. Director Since 2004
  • Mr. Stevens was appointed Chairman and a Non-Executive Director of Wright Medical Group N.V. effective October 2015 in connection with the merger of Wright Medical Group, Inc. and Tornier N.V. Previously, Mr. Stevens served as a Director of Wright Medical Group, Inc. from January 2004 to October 2015 and Chairman from 2009 to October 2015. Mr. Stevens served as interim Chief Executive Officer of Wright Medical Group, Inc. from April 2011 to September 2011. He has been a private investor since 2006. Mr. Stevens was the Chief Executive Officer of Accredo Health Group, Inc., a subsidiary of Medco Health Solutions, Inc., from 2005 to 2006. He was the Chairman of the Board and Chief Executive Officer of Accredo Health, Inc. from 1996 to 2005. Mr. Stevens was the President and Chief Operating Officer of the predecessor companies of Accredo Health from their inception in 1983 until 1996. He is a member of the board of directors of Allscripts Healthcare Solutions, Inc., a public company. Mr. Stevens previously was a member of the board of directors of Viasystems Group, Inc., a public company from 2012 to 2015, when it was acquired by TTM Technologies, Inc., Medco Health Solutions, Inc., a public company, from 2006 until 2012 when it was acquired by Express Scripts Holding Company, and Thomas & Betts Corporation, a public company, from 2004 to 2012, when it was acquired by ABB Ltd.
  • Richard F. WallmanNon-Executive Director
    Formerly Senior Vice President and
    Chief Financial Officer of Honeywell International, Inc.
  • Mr. Wallman has served as a Non-Executive Director since December 2008. From 1995 through his retirement in 2003, Mr. Wallman served as Senior Vice President and Chief Financial Officer of Honeywell International, Inc., a diversified technology company, and AlliedSignal, Inc., a diversified technology company (prior to its merger with Honeywell International, Inc.). Prior to joining AlliedSignal, Inc. as Chief Financial Officer, Mr. Wallman served as Controller of International Business Machines Corporation. Mr. Wallman currently serves as a member of the board of directors of Charles River Laboratories International, Inc., Convergys Corporation, Extended Stay America, Inc. and its wholly subsidiary ESH Hospitality, Inc., and Roper Technologies, Inc., all public companies. During the past five years, Mr. Wallman previously served on the board of directors of Ariba, Inc. and Dana Holding Corporation, both public companies. Mr. Wallman holds a Master of Business Administration from the University of Chicago Booth School of Business with concentrations in finance and accounting and a Bachelor of Science in Electrical Engineering from Vanderbilt University.
  • Elizabeth H. WeathermanNon-Executive Director
    Special Limited Partner,
    Warburg Pincus LLC
  • Ms. Weatherman has served as a Non-Executive Director since July 2006. Ms. Weatherman was appointed a Non-Executive Director of Tornier N.V. in connection with the securityholders’ agreement that Tornier entered into with certain of its shareholders. Ms. Weatherman has been a Special Limited Partner of Warburg Pincus LLC, a private equity firm, since January 2016. Ms. Weatherman previously was a Partner of Warburg Pincus & Co., a Member and Managing Director of Warburg Pincus LLC and a member of the firm’s Executive Management Group. Ms. Weatherman joined Warburg Pincus in 1988 and primarily focused on the firm’s healthcare investment activities. Ms. Weatherman currently serves on the board of directors of several privately held companies. Ms. Weatherman previously served on the board of directors of several publicly held companies, primarily in the medical device industry, including ev3 Inc., Wright Medical Group, Inc. and Kyphon Inc. Ms. Weatherman earned a Master of Business Administration from the Stanford Graduate School of Business and a Bachelor of Arts from Mount Holyoke College.